Renvela and Cataract - a phase IV clinical study of FDA data

Summary:

Cataract is reported as a side effect among people who take Renvela (sevelamer carbonate), especially for people who are male, 60+ old, also take Prolia, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Cataract when taking Renvela. It is created by eHealthMe based on reports of 10,884 people who have side effects when taking Renvela from the FDA, and is updated regularly.

What is Renvela?

Renvela has active ingredients of sevelamer carbonate. eHealthMe is studying from 10,923 Renvela users. Check the latest studies of Renvela.

What is Cataract?

Cataract (clouding of the lens inside the eye) is found to be associated with 1,892 drugs and 2,131 conditions by eHealthMe. Check the latest studies of Cataract.

On Jul, 15, 2026

10,884 people reported to have side effects when taking Renvela.
Among them, 16 people (0.15%) have Cataract.

Among these 16 people:

What is the gender of people who have Cataract when taking Renvela? *

female: 43.75 %
male: 56.25 %

What is the age of people who have Cataract when taking Renvela? *

What are other drugs people take besides Renvela? *

What are other side effects people have besides Cataract? *

Glaucoma (increased fluid pressure in the eye with vision loss): 4 people, 25.00%
Wound: 3 people, 18.75%
Shunt Stenosis (narrowing of shunt): 3 people, 18.75%
Weight Decreased: 3 people, 18.75%
Macular Degeneration (painless eye condition that leads to the gradual loss of central vision): 3 people, 18.75%
Inflammation: 3 people, 18.75%
Hypocalcaemia (levels of calcium in blood serum are abnormally low): 3 people, 18.75%
Hypoaesthesia (reduced sense of touch or sensation): 3 people, 18.75%
Device Failure: 3 people, 18.75%
Gout (uric acid crystals building up in the body): 3 people, 18.75%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 6 people, 37.50%
High Blood Pressure: 4 people, 25.00%
Oedema (fluid collection in tissue): 3 people, 18.75%
Inflammation: 3 people, 18.75%
Hypoparathyroidism (inadequate secretion of parathyroid hormone resulting in abnormally low levels of calcium in the blood): 3 people, 18.75%
Sleep Disorder: 2 people, 12.50%
Diabetes: 2 people, 12.50%
Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 2 people, 12.50%
Diabetic Retinopathy (damage to the retina caused by complications of diabetes): 2 people, 12.50%
Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Renvela and have Cataract?

- Check whether Cataract is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Renvela:

Renvela (10,923 reports)

Cataract treatments and more:

Cataract (70,565 reports)

Browse all side effects of Renvela:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cataract:

Cataract (1,892 drugs)

Browse all the conditions that are associated with Cataract:

Cataract (2,131 conditions)

Related publications that referenced our studies

Lin SY, Lin CL, Ju SW, Wang IK, Lin CC, Lin CH, Hsu WH, Liang JA, "Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study", PloS one, 2017 Mar .
Dsouza MC, "Could risperidone have caused the cataract?: A case report and review of literature", Journal of Research in Psychiatry and Behavioral Science, 2015 Jan .
Dsouza MC, "COULD RISPERIDONE HAVE CAUSED THE CATARACT", JRPBS, 2015 Jan .
Lin SY, Lin CL, Ju SW, Wang IK, Lin CC, Lin CH, Hsu WH, Liang JA, "Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study", PloS one, 2017 Mar .
Dsouza MC, "Could risperidone have caused the cataract?: A case report and review of literature", Journal of Research in Psychiatry and Behavioral Science, 2015 Jan .
Dsouza MC, "COULD RISPERIDONE HAVE CAUSED THE CATARACT", JRPBS, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on sevelamer carbonate (the active ingredients of Renvela) and Renvela (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.